COVID-era juggernaut Moderna spikes 160% after successful late-stage trial for melanoma drug
mimisabreena
Thursday, August 20, 2026
Adam Glanzman/Bloomberg via Getty Images Moderna stock surged as much as 160% on Wednesday on news of a successful late-stage cancer-drug tr...Read More
COVID-era juggernaut Moderna spikes 160% after successful late-stage trial for melanoma drug
Reviewed by mimisabreena
on
Thursday, August 20, 2026
Rating:
Reviewed by mimisabreena
on
Thursday, August 20, 2026
Rating:
